COSCIENS Biopharma Inc. Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities
COSCIENS Biopharma Inc. (CSCIF) reported Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities of $9.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities · last filed 2026-03-25
- COSCIENS Biopharma Inc. adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-06-30 was -$3.00K.
- COSCIENS Biopharma Inc. adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2025-03-31 was $3.00K.
- COSCIENS Biopharma Inc. adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2024-12-31 was $0.00.
- COSCIENS Biopharma Inc. adjustments for increase decrease in deferred income including contract liabilities for the quarter ending 2024-09-30 was $217.00K, a 703.70% increase year-over-year.
| Period end | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 3 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 3 month as first filed | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 6 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 6 month as first filed | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 9 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 9 month as first filed | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 12 month | Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $9.00K 20-F · filed 2026-03-25 | |||||||
| 2025-06-30 | -$3.00K 6-K · filed 2025-08-14 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $217.00K derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | $3.00K 6-K · filed 2025-05-13 | $3.00K derived: sum of 2 quarters · filed 2026-03-25 | $220.00K derived: sum of 3 quarters · filed 2026-03-25 | |||||
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $217.00K derived: sum of 2 quarters · filed 2026-03-25 | $217.00K 20-F · filed 2026-03-25 | |||||
| 2024-09-30 | $217.00K 6-K · filed 2025-11-12 | $217.00K 6-K · filed 2025-11-12 | ||||||
| 2023-12-31 | -$2.70M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$2.67M derived: sum of 2 quarters · filed 2024-07-17 | -$1.47M derived: sum of 3 quarters · filed 2024-07-17 | -$1.31M 20-F/A · filed 2024-07-17 | ||||
| 2023-09-30 | $27.00K 6-K · filed 2023-11-09 | $1.23M derived: sum of 2 quarters · filed 2023-11-09 | $1.39M 6-K · filed 2023-11-09 | $2.94M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2023-06-30 | $1.21M 6-K · filed 2023-08-09 | $1.36M 6-K · filed 2023-08-09 | $2.92M derived: sum of 3 quarters · filed 2024-07-17 | $2.32M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2023-03-31 | -$154.00K 6-K · filed 2024-05-16 | $154.00K 6-K · filed 2023-05-09 | $1.71M derived: sum of 2 quarters · filed 2024-07-17 | $1.12M derived: sum of 3 quarters · filed 2024-07-17 | $116.00K derived: sum of 4 quarters · filed 2024-07-17 | |||
| 2022-12-31 | $1.87M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $1.27M derived: sum of 2 quarters · filed 2024-07-17 | $270.00K derived: sum of 3 quarters · filed 2024-07-17 | $441.00K 20-F/A · filed 2024-07-17 | -$441.00K 20-F · filed 2023-03-23 | |||
| 2022-09-30 | -$595.00K 6-K · filed 2023-11-09 | $595.00K 6-K · filed 2022-11-03 | -$1.60M derived: sum of 2 quarters · filed 2023-11-09 | -$1.43M 6-K · filed 2023-11-09 | $1.43M 6-K · filed 2022-11-03 | -$200.00K derived: sum of 4 quarters · filed 2024-07-17 | ||
| 2022-06-30 | -$1.00M 6-K · filed 2023-08-09 | $1.00M 6-K/A · filed 2022-08-04 | -$1.01M 6-K · filed 2023-08-09 | $1.01M 6-K/A · filed 2022-08-04 | $395.00K derived: sum of 3 quarters · filed 2024-07-17 | $713.00K derived: sum of 4 quarters · filed 2024-07-17 | ||
| 2022-03-31 | -$8.00K 6-K · filed 2023-05-09 | $8.00K 6-K · filed 2022-05-11 | $1.40M derived: sum of 2 quarters · filed 2024-07-17 | $1.71M derived: sum of 3 quarters · filed 2024-07-17 | $1.72M derived: sum of 4 quarters · filed 2024-07-17 | |||
| 2021-12-31 | $1.40M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $1.72M derived: sum of 2 quarters · filed 2024-07-17 | $1.73M derived: sum of 3 quarters · filed 2024-07-17 | $3.01M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | $318.00K 6-K · filed 2022-11-03 | $321.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.61M 6-K · filed 2022-11-03 | |||||
| 2021-06-30 | $3.00K 6-K/A · filed 2022-08-04 | $1.23M 6-K/A · filed 2022-08-04 | ||||||
| 2021-03-31 | $1.23M 6-K · filed 2022-05-11 | |||||||
| 2020-12-31 | -$3.03M 20-F/A · filed 2024-02-15 | $3.03M 20-F · filed 2022-03-29 | ||||||
| 2019-12-31 | $743.00K 20-F · filed 2022-03-29 |